Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227188
Status:
COMPLETED
Last Update Posted:
2012-11-29
First Post:
2005-09-13
Brief Title:
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease IPD in the Paediatric Population in Spain
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population children younger than 5 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None